Summary: Despite recent setbacks and challenges faced by top EV companies like Tesla and General Motors, the EV industry is seen as an adolescent industry on the brink of major growth, especially with other automakers like Ford, Hyundai, Rivian, and Mercedes experiencing significant sales increases. GM is planning to increase EV offerings and build between 200,000 and 300,000 EVs in 2024.
Full articleSummary: Coke and Pepsi Teamsters at Local 135 in Indiana successfully negotiated stronger contracts through open bargaining, informing and involving members, and taking action including practice picketing. Strategies included engaging members in the negotiation process, encouraging participation in contract actions, and utilizing social media for communication.
Full articleSummary: US Bancorp DE raised its stake in shares of MetLife, Inc. by 1.3% in the 4th quarter, according to its most recent disclosure with the SEC. Several other hedge funds also purchased shares of MET. Analysts have set new price targets for MET with an average rating of 'Moderate Buy'. MetLife announced an increase in dividend and a stock buyback program. Insider buying and selling activity was reported for MET.
Full articleSummary: Gilead Sciences included in Biden Cancer Moonshot initiative to improve cancer screenings for U.S. workers
Full articleSummary: Shocking footage shows a Tesla in 'Full Self Driving' mode narrowly avoiding a crash on rail tracks in Ohio after failing to detect a passing train, raising concerns about the technology's reliability and safety.
Full articleSummary: Broadcom Inc. (AVGO) ended the recent trading session with a slight increase in stock price. The company is expected to announce its earnings on June 12, 2024, with a positive anticipated rise in EPS and revenue compared to the previous year. Investors should pay attention to analyst estimates and the Zacks Rank system, which currently rates AVGO as a Hold (#3). AVGO is trading at a discount compared to the industry average in terms of Forward P/E ratio.
Full articleSummary: Coca-Cola debuts a new limited edition flavor, Coca-Cola Wozzaah Zero Sugar, inspired by African culture with vibrant tropical flavors and colorful can design.
Full articleSummary: SageView Advisory Group LLC lowered its position in shares of Caterpillar Inc. by 57.4% during the fourth quarter, while several large investors made changes to their positions in the company. Analysts have mixed ratings on the stock, with a consensus rating of 'Hold' and an average target price of $323.35. Insiders have been active with stock transactions, including a recent purchase by Director David Maclennan.
Full articleSummary: Costco has partnered with Uber to offer significant discounts on grocery orders through Uber Eats, including a recent 50% off discount on Costco orders up to $70 in savings. Uber Eats is also providing additional benefits such as $0 delivery fee and 5% off grocery orders.
Full articleSummary: Coca-Cola is debuting a new product, Coca-Cola Wozzaah Zero Sugar, inspired by African culture with tropical flavors. The can design is vibrant and colorful. The product will be available for a limited time in select markets.
Full articleSummary: Nike (NKE) closed slightly higher at $92 with a +0.27% change, outperforming the S&P 500 but lagging behind Nasdaq. Analysts are predicting a 30.3% growth in EPS for the upcoming earnings report, with revenue projected to rise by 0.71% compared to the previous year. Nike currently holds a Zacks Rank of #3 (Hold).
Full articleSummary: Legacy Advisors LLC reduced its position in Amgen by 21.3% in the fourth quarter, while a number of other large investors also modified their holdings of the company. Additionally, SVP Nancy A. Grygiel sold 2,117 shares of Amgen stock. Analysts have provided various ratings for AMGN, with an average rating of 'Moderate Buy' and a consensus target price of $305.65. Amgen's stock traded down 1.8% on Tuesday, reaching $300.19.
Full articleSummary: Pharmaceutical regulators approved Amgen's biosimilar Bkemv as a treatment for rare diseases, including paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, previously treated by Soliris developed by AstraZeneca-owned Alexion Pharmaceuticals.
Full articleSummary: Amgen's biosimilar Bkemv has been approved by pharmaceutical regulators for treating rare diseases paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, marking it as the first interchangeable biosimilar to Soliris for these treatments.
Full articleSummary: Capital One Financial and Walmart have ended their exclusive credit card agreement, leading to Capital One losing its partnership with the world's largest retailer due to disputes over transaction updates and customer service. Walmart accused Capital One of being slow in updating transactions and failing to promptly replace lost cards. Capital One will retain ownership of the existing credit card portfolio, while Walmart is expected to seek a new credit card issuer.
Full articleSummary: The consumer staples sector has been underperforming recently due to rising input costs, intense competition, strained margins, and higher operating expenses. This trend is expected to continue for quite some time. Companies like Sysco, Colgate, Campbell Soup, and Kimberly-Clark are facing challenges in terms of margins and profits.
Full articleSummary: The U.S. FDA approved Amgen's biosimilar Bkemv, the first competitor to AstraZeneca's Soliris for rare blood disorders, with a black-box warning about serious bacterial infections.
Full articleSummary: Stanley Goldstein, one of the co-founders of CVS, passed away at the age of 89. His visionary approach in turning a single store into a retail and health-care giant was a significant contribution to CVS's success.
Full articleSummary: Intuit (Nasdaq: INTU) may issue a stock split after Nvidia due to factors like elevated stock price, being a portfolio favorite, and historical stock split practices.
Full articleSummary: Jensen Investment Management Inc. trimmed its holdings in PepsiCo by 2.1% in the fourth quarter, reducing their position to 4,824,344 shares worth $819,367,000. CEO Ramkumar Krishnan sold 5,620 shares at $178.00 each. PepsiCo also increased its dividend payout to a $1.355 quarterly dividend.
Full articleSummary: Colgate-Palmolive had its price target raised by Morgan Stanley and received positive ratings from various equities analysts. The company reported a strong quarterly earnings and increased its dividend. Insiders at Colgate-Palmolive have been actively selling shares, while hedge funds have been adjusting their positions on the stock.
Full articleSummary: NextEra Energy, Inc. announced that a shareholder proposal titled 'Board Matrix' was not approved by the Company shareholders.
Full articleSummary: Broadcom Inc. employees are graduating with certificates in electronics assembly through a partnership with Front Range Community College. The collaboration aims to help employees advance their positions at Broadcom by providing college coursework on-site.
Full articleSummary: Stifel Financial Corp lessened its stake in Colgate-Palmolive by 0.6% in the 4th quarter, with other institutional investors also modifying their holdings of CL. Colgate-Palmolive stock is down 1.5%. The company last reported earnings exceeding estimates, and announced a dividend increase. Insider buying and selling activities were disclosed. Several analysts have issued buy ratings for the stock.
Full articleSummary: Portfolio Design Labs LLC acquired a new stake in General Dynamics in the fourth quarter, while other institutional investors also increased their holdings. Insiders at General Dynamics have been actively involved in buying and selling stocks recently. Some Wall Street analysts have raised price targets and provided positive ratings for General Dynamics. The company's stock price was down by 0.7% on Tuesday.
Full articleSummary: Nasdaq reached a new high with Nvidia's gain, while Dow was impacted by rising US Treasury yields. Consumer confidence increased in May. Chevron's acquisition of Hess faces a challenge from ExxonMobil. GameStop surged after raising $933.4 million.
Full articleSummary: Analysts have published diverse ratings on Colgate-Palmolive in the last three months, with an average price target of $95.33, showing a 4.86% increase from the previous target. Several analysts have raised their ratings and price targets for CL stock.
Full article